Bipolar Disorder Drugs Market Size | COVID-19 Impact Analysis | Forecast to 2027
The global bipolar disorder drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The primary factor attributable to the market growth includes the rising cases of bipolar disorder all over the globe. Adding to this, the underlying cause of bipolarity such as high stress, substance abuse, and others, have also grown among the global population. As a matter of fact, with the shifting perspective of the global population toward mental health, there is an increased demand for diagnosis and treatment of various mental disorders. Bipolar disorder, being one such prevalent issue, is thus anticipated to spur its drugs market. As per the Institute for Health Metrics and Evaluation (IHME), Global Burden of Diseases, the prevalence of bipolar disorder across the world varies from 0.3 to 1.2% by country.
To Request a Sample of our Report on Bipolar Disorder
Drugs Market: https://www.omrglobal.com/request-sample/bipolar-disorder-drugs-market
In 2017 around 46 million
people in the world had bipolar disorder, with 52% and 48% being female and
male, respectively. The typical age of onset is the late teens or the early
20s, and a history of depression is common in people diagnosed with bipolar. Although
contrary to the general misconception, the possibility of men and women being
affected by bipolar disorder is similar. Thus, the surge in the cases of the
disease among females as well as males coupled with the rising need to manage
the disease effectively is projected to lead to the growth of the market. As a
measure to increase the awareness about mental disorders and depression,
growing initiatives by the government institutes, are further anticipated to
rise in the future years.
Market
Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
·
By Drug Class
·
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape: GlaxoSmithKline
plc, Pfizer Inc., and AbbVie Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Bipolar Disorder Drugs Market is Available @ https://www.omrglobal.com/industry-reports/bipolar-disorder-drugs-market
Global Bipolar Disorder Drugs Market Report by Segment
By
Drug Class
• Mood Stabilizers
• Antipsychotic
• Antidepressant
• Antianxiety
Global
Bipolar Disorder Drugs Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment